source
- STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and morePresident Trump heralded a drug-pricing agreement with Regeneron, closing the last of 17 deals sought by the White HouseSTAT · 4mo ago↗ source
- STAT+: Sanofi MS drug gets positive review in Europe following FDAA multiple sclerosis drug from Sanofi that was rejected late last year by the FDA found a warmer reception in Europe.STAT · 4mo ago↗ source
- Sanofi’s tolebrutinib gets CHMP backing for certain MS patients despite FDA rejectionSanofi’s tolebrutinib is on track to get an approval in Europe for a type of multiple sclerosis even after receiving a complete response letter from the FDA in December. On Friday, the European Med…Endpoints · 4mo ago